| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |